(Q30878925)

English

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

0 references

0 references

phase III clinical trial

0 references

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

Robert J van Soest

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

10

object named as

I F Tannock

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Arnoud J Templeton

2

object named as

A J Templeton

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Francisco Vera-Badillo

3

object named as

F E Vera-Badillo

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

F Mercier

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

G Sonpavde

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

B Tombal

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

M Rosenthal

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

M A Eisenberger

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

R de Wit

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

15 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

743-749

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Castration-resistant prostate cancer: from new pathophysiology to new treatment

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

Abiraterone in metastatic prostate cancer without previous chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

Enzalutamide in metastatic prostate cancer before chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

Protumor and antitumor functions of neutrophil granulocytes

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU569

21 January 2018

Identifiers

10.1093/ANNONC/MDU569

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

release_gwd4slvakjgkxhkvk3vy2cyovi

1 reference

https://api.fatcat.wiki/v0/release/gwd4slvakjgkxhkvk3vy2cyovi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25515657%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30878925&oldid=1856135622"